This review highlights advances in immunotherapy methods and combination strategies in cancer treatments, suggesting personalized approaches may enhance outcomes.
Key Points
Next-generation cancer immunotherapy aims to overcome resistance by targeting multiple immune regulation layers.
Combination strategies integrating immune checkpoint inhibitors and cytokines have shown potential in enhancing treatment efficacy.
Biomarker-guided approaches are critical for personalizing immunotherapies and mitigating adverse events in patients.
Emerging technologies like AI and microbiome-targeted interventions could reshape the future of cancer treatment.